Skip to main content

clinical trial Archives

First subject enrolled in international HIV prevention study

Apr. 14, 2016—This month an international HIV prevention trial was launched that is testing the infection-preventing prowess of a monoclonal antibody called VRCO1.

Read more


VUMC study finds statins do not ease kidney injury following cardiac surgery

Feb. 23, 2016—Among doctors, it is widely believed that a class of drugs called statins, which are used to lower cholesterol, might help patients tolerate the stress of cardiac surgery. Not so, according to a five-year, placebo-controlled, double-blinded randomized clinical trial conducted at Vanderbilt University Medical Center, published today in the Journal of the American Medical Association....

Read more


Diabetes trial targets body’s ability to produce insulin

Sep. 10, 2015—Kiersten Eaddy had long looked forward to her high school graduation day and joining her classmates to celebrate the accomplishment.

Read more


ResearchMatch adds new clinical trials feature

Mar. 26, 2015—Patients seeking to participate in clinical trials have a new option in online tools for finding studies that might offer hope for their problem or condition.

Read more


Vanderbilt to study use of plasma on LifeFlight, extends trial to Rutherford County base

Feb. 25, 2015—Vanderbilt University Medical Center is participating in a national trial to see if outcomes for critically injured patients with uncontrolled bleeding can be improved by administering plasma to these patients while in flight to the hospital. Randomized patients who are at risk of hemorrhaging could receive two units of plasma, which can improve a patient’s...

Read more


VU study explores optimal timing for pertussis vaccine

Feb. 12, 2015—Pertussis, commonly known as whooping cough, is experiencing a resurgence, and its tiniest victims are not armed to battle the contagious respiratory infection.

Read more


Research Subjects’ Bill of Rights available online

Oct. 13, 2014—As the number of opportunities to participate in research studies continues to grow, the Vanderbilt Human Research Protection Program (HRPP) would like study participants to be aware of the Research Subjects’ Bill of Rights.

Read more


DBS for Parkinson’s trial moves to next level

Apr. 3, 2014—A long-term Vanderbilt University Medical Center study of deep brain stimulation (DBS) in early-stage Parkinson’s disease has received approval from the Food and Drug Administration (FDA) to continue in a pivotal, phase III, large-scale safety and efficacy trial.

Read more


Heart Institute studying absorbable coronary stent

Nov. 14, 2013—Vanderbilt Heart and Vascular Institute is participating in a clinical trial to evaluate a medical device for the treatment of coronary artery disease.

Read more


Vanderbilt to study use of plasma on LifeFlight

Oct. 29, 2013—Vanderbilt University Medical Center will participate in a national trial to see if outcomes for critically injured patients with uncontrolled bleeding can be improved by administering plasma to these patients while in flight to the hospital.

Read more


Glucose control study gives patients new path to health

Oct. 24, 2013—The IDIOM study is designed to compare how a diet with moderate caloric restriction, alone or with long-acting insulin, affects areas of the brain’s dopamine system that are involved in food intake, reward and the sense of pleasure people get from eating.

Read more


VU tracking drug’s ability to prevent type 1 diabetes

Sep. 12, 2013—Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D.

Read more


Page 2 of 3123